SHAREHOLDER ALERT: CLAIMSFILER REMINDS APPH, BMY, EAR, HEPS INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
SHAREHOLDER ALERT: WeissLaw LLP Reminds COLB, XLRN, ACBI. and ECHO Shareholders About Its Ongoing Investigations Life Science Investing
Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021 Pharmaceutical Investing
Bausch + Lomb Launches Biotrue® Eye Care Recycling Program in Collaboration With TerraCycle in the United States Pharmaceutical Investing
Merck Presents New Data from Ongoing Phase 2b Clinical Trial Evaluating Efficacy and Safety of Investigational Islatravir in Combination With Doravirine Through 144 Weeks for HIV-1 Treatment at EACS 2021 Pharmaceutical Investing
The Medicines Patent Pool and Merck Enter Into License Agreement for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, to Increase Broad Access in Low- and Middle-Income Countries Pharmaceutical Investing
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of APPH, BMY, EAR and HNST Pharmaceutical Investing
FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech COVID-19 Vaccine in Children 5 to <12 Years Pharmaceutical Investing
Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021 Pharmaceutical Investing
Numinus to Participate in Microdose Hosted Events: Psychedelic Capital and Wonderland: Miami Pharmaceutical Investing
